Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road.
10.1007/s11655-018-3007-1
- Author:
Jing-Si WANG
1
;
Qiu-Yun ZHANG
2
;
Jin-Lian CHENG
3
;
Lan-Yu CHEN
4
;
Nai-Li YAO
5
;
Gui-Zhi SUN
6
;
Yu-Ling CHU
5
Author Information
1. Department of Hepatology, Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Beijing, 100010, China.
2. College of Traditional Chinese Medicine Affiliated to Capital Medical University, Beijing, 100069, China. zhangqiuyun8202@aliyun.com.
3. Department of Good Clinical Practice, Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Beijing, 100010, China.
4. Department of Hepatology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053, China.
5. Department of Gastroenterology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053, China.
6. Department of Oncology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053, China.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
angiogenesis;
hepatic fibrosis;
review
- From:
Chinese journal of integrative medicine
2018;24(9):713-720
- CountryChina
- Language:English
-
Abstract:
Hepatic fibrosis is a common feature of almost all chronic liver diseases. Formation of new vessels (angiogenesis) is a process strictly related to the progressive fibrogenesis which leads to cirrhosis and liver cancer. This review mainly concerns the relationship between angiogenesis and hepatic fibrosis, by considering the mechanism of angiogenesis, cells in angiogenesis, anti-angiogenic and Chinese medicine therapies.
